PEPTONIC medical AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was SEK 12.12 million compared to SEK 12.68 million a year ago. Net loss was SEK 7.48 million compared to SEK 9.04 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.04 a year ago.
For the six months, revenue was SEK 21.19 million compared to SEK 22.11 million a year ago. Net loss was SEK 15.48 million compared to SEK 20.3 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.08 a year ago.